Inventiva SA said Jean-Louis Abitbol will retire as chief medical officer at the end of April 2019.
The French biopharmaceutical company named Marie-Paule Richard as its new chief medical officer.
Previously, Richard worked as chief medical officer of the Belgian biotech firm TiGenix NV from 2014, which was recently acquired by Japan-based Takeda Pharmaceutical Co. Ltd.
The company also named David Nikodem as vice president of U.S. operations. Before joining the company, Nikodem founded Sapidus Partners LLC, a U.S.-based consulting group, in 2014.